|
Name
of applicant:
|
GlaxoSmithKline
plc
|
|||
|
Name of
scheme:
|
GlaxoSmithKline
plc 2009 Deferred Annual Bonus Plan
|
|||
|
Period
of return:
|
From:
|
1
November 2019
|
To:
|
30
April 2020
|
|
Balance
of unallotted securities under scheme(s) from previous
return:
|
153,724
|
|||
|
Plus: The amount by which the block scheme(s) has
been increased since the date of the last return (if any increase
has been applied for):
|
370,000
|
|||
|
Less: Number of securities issued/allotted under
scheme(s) during period (see LR3.5.7G):
|
388,348
|
|||
|
Equals: Balance under scheme(s) not yet
issued/allotted at end of period:
|
135,376
|
|||
|
Name of
contact:
|
Victoria
Whyte
|
|
Telephone
number of contact:
|
020
8047 5000
|
|
Name
of applicant:
|
GlaxoSmithKline
plc
|
|||
|
Name of
scheme:
|
GlaxoSmithKline
2009 Share Option Plan - Ordinary Shares
|
|||
|
Period
of return:
|
From:
|
1
November 2019
|
To:
|
30
April 2020
|
|
Balance
of unallotted securities under scheme(s) from previous
return:
|
835,095
|
|||
|
Plus: The amount by which the block scheme(s) has
been increased since the date of the last return (if any increase
has been applied for):
|
0
|
|||
|
Less: Number of securities issued/allotted under
scheme(s) during period (see LR3.5.7G):
|
581,004
|
|||
|
Equals: Balance under scheme(s) not yet
issued/allotted at end of period:
|
254,091
|
|||
|
Name of
contact:
|
Victoria
Whyte
|
|
Telephone
number of contact:
|
020
8047 5000
|
|
Name
of applicant:
|
GlaxoSmithKline
plc
|
|||
|
Name of
scheme:
|
GlaxoSmithKline
2009 Share Option Plan - ADS
|
|||
|
Period
of return:
|
From:
|
1
November 2019
|
To:
|
30
April 2020
|
|
Balance
of unallotted securities under scheme(s) from previous
return:
|
5,391,416
|
|||
|
Plus: The amount by which the block scheme(s) has
been increased since the date of the last return (if any increase
has been applied for):
|
0
|
|||
|
Less: Number of securities issued/allotted under
scheme(s) during period (see LR3.5.7G):
|
698,736
|
|||
|
Equals: Balance under scheme(s) not yet
issued/allotted at end of period:
|
4,692,680
|
|||
|
Name of
contact:
|
Victoria
Whyte
|
|
Telephone
number of contact:
|
020
8047 5000
|
|
Name
of applicant:
|
GlaxoSmithKline
plc
|
|||
|
Name of
scheme:
|
GlaxoSmithKline
plc Share Save Plan 2012
|
|||
|
Period
of return:
|
From:
|
1
November 2019
|
To:
|
30
April 2020
|
|
Balance
of unallotted securities under scheme(s) from previous
return:
|
2,145,812
|
|||
|
Plus: The amount by which the block scheme(s) has
been increased since the date of the last return (if any increase
has been applied for):
|
0
|
|||
|
Less: Number of securities issued/allotted under
scheme(s) during period (see LR3.5.7G):
|
698,407
|
|||
|
Equals: Balance under scheme(s) not yet
issued/allotted at end of period:
|
1,447,405
|
|||
|
Name of
contact:
|
Victoria
Whyte
|
|
Telephone
number of contact:
|
020
8047 5000
|
|
|
GlaxoSmithKline plc
|
|
|
(Registrant)
|
|
|
|
|
Date: May
26, 2020
|
|
|
|
|
|
|
By:/s/ VICTORIA
WHYTE
--------------------------
|
|
|
|
|
|
Victoria Whyte
|
|
|
Authorised
Signatory for and on
|
|
|
behalf
of GlaxoSmithKline plc
|